Multi-omics longitudinal analyses in stages I to III CRC patients: Surveillance liquid biopsy test to predict early recurrence and enable risk-stratified postoperative CRC management. Liu, X., Zhang, Y., Zhu, X., Thyparambil, S. P., Liao, W., Zheng, X., You, J., Masood, A., Li, Z., Yang, G., Yao, X., Hao, S., Heaton, R., Schilling, J., Sylvester, K. G., Liao, J., Gao, F., Lan, P., Ling, X., Wu, X. LIPPINCOTT WILLIAMS & WILKINS. 2021

View details for DOI 10.1200/JCO.2021.39.15_suppl.3613

View details for Web of Science ID 000708120602102